Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q2 2026

Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.

Institution overview
Positions
31
−4 vs. Q1 2026
Portfolio value
$1.65B
+$529.4M (+47.4%) vs. Q1 2026
Filed
Aug 14, 2026
SEC
Holdings of First Light Asset Management, LLC in Q2 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
NEONeogenomics IncCOM NEW12,279,523$179.2M10.9%+2,549,545+26.2%AddedHistory
SIBNSI-BONE, Inc.COM8,127,985$132.6M8.1%+2,774,795+51.8%AddedHistory
AXGNAxogen, Inc.COM2,748,361$126.9M7.7%−1,254,407−31.3%ReducedHistory
APGEApogee Therapeutics, Inc.COM930,289$123.5M7.5%+353,605+61.3%AddedHistory
PVLAPalvella Therapeutics, Inc.COM771,901$118.0M7.2%−208,857−21.3%ReducedHistory
TWSTTwist Bioscience CorpCOM727,933$74.9M4.6%−150,915−17.2%ReducedHistory
ELVNEnliven Therapeutics, Inc.COM1,360,750$69.1M4.2%+1,158,883+574.1%AddedHistory
GHGuardant Health, Inc.COM441,586$66.3M4.0%+161,287+57.5%AddedHistory
MASS908 Devices Inc.COM6,282,804$54.7M3.3%+210,241+3.5%AddedHistory
AMLXAmylyx Pharmaceuticals, Inc.COM3,023,256$54.3M3.3%−167,389−5.2%ReducedHistory
WGSGeneDx Holdings Corp.COM CL A783,923$53.8M3.3%+540,996+222.7%AddedHistory
SLPSimulations Plus, Inc.COM2,792,677$51.1M3.1%+159,854+6.1%AddedHistory
TNDMTandem Diabetes Care IncCOM NEW3,383,553$51.1M3.1%+2,068,838+157.4%AddedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,360,866$50.9M3.1%+271,196+24.9%AddedHistory
NPCENeuroPace IncCOM2,861,167$45.5M2.8%+401,201+16.3%AddedHistory
EWTXEdgewise Therapeutics, Inc.COM1,095,171$44.5M2.7%+93,325+9.3%AddedHistory
ANABAnaptysbio, IncCOM582,004$39.3M2.4%+16,573+2.9%AddedHistory
TRVITrevi Therapeutics, Inc.COM2,097,215$39.1M2.4%+2,097,215NewHistory
SEPNSepterna, Inc.COM963,260$32.3M2.0%+230,400+31.4%AddedHistory
TLSITriSalus Life Sciences, Inc.COM6,552,491$29.8M1.8%+1,485,664+29.3%AddedHistory
TECXTectonic Therapeutic, Inc.COM800,726$27.5M1.7%+152,983+23.6%AddedHistory
HCATHealth Catalyst, Inc.COM12,810,861$25.5M1.5%−67,839−0.5%ReducedHistory
BFLYButterfly Network, Inc.COM CL A2,642,404$22.2M1.4%−17,763−0.7%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM246,577$21.2M1.3%−61,161−19.9%ReducedHistory
PCVXVaxcyte, Inc.COM345,157$20.1M1.2%+203,373+143.4%AddedHistory
IRTCiRhythm Holdings, Inc.COM167,092$19.9M1.2%−1,024−0.6%ReducedHistory
OMCLOmnicell, Inc.COM452,324$18.8M1.1%−37,522−7.7%ReducedHistory
ATRCAtriCure, Inc.COM567,838$15.9M1.0%−161,683−22.2%ReducedHistory
KRMDKORU Medical Systems, Inc.COM3,387,902$14.2M0.9%−380,478−10.1%ReducedHistory
TCMDTactile Systems Technology IncCOM462,562$13.8M0.8%+462,562NewHistory
RYTMRhythm Pharmaceuticals, Inc.COM85,765$9.52M0.6%−1,416−1.6%ReducedHistory

Sold out since Q1 2026 (6)

Positions held at the end of Q1 2026 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q1 2026
SecurityClassShares in Q1 2026Value in Q1 2026% of portfolio in Q1 2026History
CNTACentessa Pharmaceuticals plcSPONSORED ADS1,560,991$62.0M5.6%History
WVEWave Life Sciences, Inc.SHS1,843,968$13.4M1.2%History
VERAVera Therapeutics, Inc.CL A313,906$12.6M1.1%History
MDXGMimedx Group, Inc.COM2,842,892$11.2M1.0%History
SGPSpyGlass Pharma, Inc.COM SHS375,000$9.72M0.9%History
ORGOOrganogenesis Holdings Inc.COM3,498,533$8.29M0.7%History